Abstract
Twenty-seven uremic patients (blood urea: 58.2±2.2 mmol/l; blood creatinine: 1,069±53 μnol/l; mean±SE) on maintenance dialysis were investigated immediately before and after a dialysis session. Control data were obtained from 30 normal volunteers. Before dialysis, circulating levels of insulin-like growth factor I (IGF-I) were similar in anuric and nonanuric patients, averaging 305±24 μg/l, a value not different from that observed in normal controls (262±16 μg/l). IGF-I levels were not modified by dialysis. In contrast, GH values were significantly higher in uremic patients (3.6± 0.6 μg/l) than in normal controls (2.5±0.5 μg/l) and decreased significantly after the dialysis session (0.8±0.1 μg/). IGF-I values were positively correlated with GH and albumin, but not with the various parameters of renal insufficiency, suggesting that in chronic renal failure, synthesis of IGF-I appears to be regulated, as in normal subjects, by growth hormone and nutritional status.
Similar content being viewed by others
References
Takano K., Hall K., Kastrup K.W., Hizuka N., Shizume K., Kawai K., Akimoto M., Takuma T., Sugino N. Serum somatomedin A in chronic renal failure. J. Clin. Endocrinol. Metab. 48: 371, 1979.
Phillips LS., Kopple J.D. Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. Metabolism 30: 1091, 1981.
Phillips S.L., Fusco A.C., Unterman T.G., del Greco F. Somatomedin inhibitor in uremia. J. Clin. Endocrinol. Metab. 59: 764, 1984.
Lee P.D.K., Hintz R.L., Sperry J.B., Baxter R.C., Powell D.R. IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr. Res. 26: 308, 1989.
Blum F., Ranke M.B., Kietzmann K., Tönshoff B., Mehls O. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia. Pediatr. Nephrol. 5: 539, 1991.
Baxter R.Ç., Brown A.S., Turtle J.R. Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin. Chem. 28: 488, 1982.
Goldberg A.C., Trivedi B., Delmez JA, Harter H.R., Daughaday W.H. Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding. J. Clin. Endocrinol. Metab. 55: 1040, 1982.
Powell D.R., Rosenfeld R.G., Baker B.K., Liu F., Hintz R.L. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum. J. Clin. Endocrinol. Metab. 63: 1186, 1986.
Powell D.R., Rosenfeld R.G., Sperry J.B., Baker B.K., Hintz R.L. Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with renal failure. Am. J. Kidney Dis. 10: 287, 1987.
Koch V.H., Lippe B.M., Nelson P.A., Boechat M.I., Sherman B.M., Fine R.N. Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure. J. Pediatr. 115: 365, 1989.
Jacob V., Le Carpentier J.E., Salzano S., Naylor V., Wild G., Brown C.B., El Nahas A.M. IGF-I, a marker of undernutrition in hemodialysis patients. Am. J. Clin. Nutr. 52: 39, 1990.
Hokken-Koelega A.C.S., Hackeng W.H.L., Stijnen T., Wit J.M., de Muinck Keizer-Schrama S.M.P.F., Drop S.L.S. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. J. Clin. Endocrinol. Metab. 71: 688, 1990.
Virasoro E., Copinschi G., Bruno O.D., Leclercq R. Radioimmunoassay of human growth hormone using a charcoal-dextran separation procedure. Clin. Chim. Acta 31: 294, 1971.
Furlanetto R.W., Underwood L.E., Van Wyk J.J., D’Ercole A.J. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radio-immunoassay. J.Clin. Invest. 60: 648, 1977.
Furlanetto R.W., Underwood L.E., Van Wyk J.J., Handwerger S. Serum immunoreactive somatomedin-C is elevated late in pregnancy. J, Clin. Endocrinol. Metab. 41: 695, 1978.
Furlanetto R.W., Marino J.M. Radioimmunoassay of somatomedin C insulin-like growth factor I. In: Barnes D., Sirbasku D.A. (Eds.), Methods in Enzymology, vol. 146, Peptide Growth Factors. Academic Press Inc., New York, 1987, p. 216.
Caufriez A., Copinschi G. IGF-I determinations in patients with chronic renal failure: an appraisal of a non-equilibrium RIA method on non acidified unextracted serum. Abstracts of the 71st Annual Meeting of the Endocrine Society: 146, 1991.
Hammerman M. R. The growth hormone-insulin-like growth factor axis in kidney. Am. J. Physiol. 257: F503, 1989.
Samaan N.A., Freeman R.M. Growth hormone levels in severe renal failure. Metabolism 19: 102, 1970.
Donnay S., Garcia-Martin F., Martin-Escobar E., De Arriba G., Agud J.L., Requejo R. Growth hormone response to acute growth hormone releasing hormone administration in uraemic patients on hemodialysis. Nephrol. Dial. Transplant. 7: 246, 1992.
El Bishti M.M., Counahan R., Bloom S.R., Chantler C. Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis. Am. J.Clin. Nutr. 31: 1865, 1978.
Olgaard K., Hagen C., McNeilly A.S. Pituitary hormones in women with chronic renal failure: the effect of chronic intermittent haemodialysis and peritoneal dialysis. Acta Endocrinol. (Copenh.) 80: 237, 1975.
Stuart M., Lazarus L., Hayes J. Serum somatomedin and growth hormone levels in chronic renal failure. IRCS 2: 1102, 1984.
Hunter W.M., Fonseka C.C., Passmore R. Growth hormone: important role in muscular exercise in adults. Science 150: 1051, 1965.
Hartog M., Havel R.J., Copinschi G., Earll J.M., Ritchie B.C. The relationship between changes in serum levels of growth hormone and mobilization of fat during exercise in man. Quart. J. Exp. Physiol. 52: 86, 1967.
Berelowitz M., Szabo M., Frohman L.A., Firestone S., Chu L., Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212: 1279, 1981.
Van Cauter E., Caufriez A., Kerkhofs M., Van Onderbergen A., Thorner M.O., Copinschi G. Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone. J. Clin. Endocrinol. Metab. 74: 1451, 1992.
Guarnieri G., Toigo G., Situlin R., Carraro M., Tamaro G. The assessment of nutritional status in chronically uremic patients. Contrib. Nephrol. 72: 73, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caufriez, A., Abramowicz, D., Vanherweghem, J.L. et al. Insulin-like growth factor I values in patients on maintenance hemodialysis: Relationship to growth hormone and albumin levels. J Endocrinol Invest 16, 691–696 (1993). https://doi.org/10.1007/BF03348913
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348913